  To contain the spread of the virus and stop the overcrowding of hospitalized
patients, the coronavirus pandemic crippled healthcare facilities, mandating
lockdowns and promoting remote work. As a result, telehealth has become
increasingly popular for offering low-risk care to patients. However, the
difficulty of preventing the next potential waves of infection has increased by
constant virus mutation into new forms and a general lack of test kits,
particularly in developing nations. In this research, a unique cloud-based
application for the early identification of individuals who may have COVID-19
infection is proposed. The application provides five modes of diagnosis from
possible symptoms (f1), cough sound (f2), specific blood biomarkers (f3), Raman
spectral data of blood specimens (f4), and ECG signal paper-based image (f5).
When a user selects an option and enters the information, the data is sent to
the cloud server. The deployed machine learning (ML) and deep learning (DL)
models classify the data in real time and inform the user of the likelihood of
COVID-19 infection. Our deployed models can classify with an accuracy of 100%,
99.80%, 99.55%, 95.65%, and 77.59% from f3, f4, f5, f2, and f1 respectively.
Moreover, the sensitivity for f2, f3, and f4 is 100%, which indicates the
correct identification of COVID positive patients. This is significant in
limiting the spread of the virus. Additionally, another ML model, as seen to
offer 92% accuracy serves to identify patients who, out of a large group of
patients admitted to the hospital cohort, need immediate critical care support
by estimating the mortality risk of patients from blood parameters. The
instantaneous multimodal nature of our technique offers multiplex and accurate
diagnostic methods, highlighting the effectiveness of telehealth as a simple,
widely available, and low-cost diagnostic solution, even for future pandemics.
